These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 36281831)
1. Therapeutic Potential of Diacerein in Management of Pain. Patel V; Joharapurkar A; Jain M Curr Drug Res Rev; 2022; 14(3):215-224. PubMed ID: 36281831 [TBL] [Abstract][Full Text] [Related]
2. Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Yaron M; Shirazi I; Yaron I Osteoarthritis Cartilage; 1999 May; 7(3):272-80. PubMed ID: 10329302 [TBL] [Abstract][Full Text] [Related]
3. Diacerein: Recent insight into pharmacological activities and molecular pathways. Almezgagi M; Zhang Y; Hezam K; Shamsan E; Gamah M; Al-Shaebi F; Abbas AB; Shoaib M; Saif B; Han Y; Jia R; Zhang W Biomed Pharmacother; 2020 Nov; 131():110594. PubMed ID: 32858499 [TBL] [Abstract][Full Text] [Related]
4. Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes. Tamura T; Kosaka N; Ishiwa J; Sato T; Nagase H; Ito A Osteoarthritis Cartilage; 2001 Apr; 9(3):257-63. PubMed ID: 11300749 [TBL] [Abstract][Full Text] [Related]
6. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone. Pelletier JP; Lajeunesse D; Reboul P; Mineau F; Fernandes JC; Sabouret P; Martel-Pelletier J J Rheumatol; 2001 Apr; 28(4):814-24. PubMed ID: 11327257 [TBL] [Abstract][Full Text] [Related]
7. Topical Diacerein Ointment for Epidermolysis Bullosa Simplex: A Review. Limmer AL; Nwannunu CE; Shah R; Coleman K; Patel RR; Mui UN; Tyring SK Skin Therapy Lett; 2019 May; 24(3):7-9. PubMed ID: 31095348 [TBL] [Abstract][Full Text] [Related]
8. Diacerein reduces the level of cartilage chondrocyte DNA fragmentation and death in experimental dog osteoarthritic cartilage at the same time that it inhibits caspase-3 and inducible nitric oxide synthase. Pelletier JP; Mineau F; Boileau C; Martel-Pelletier J Clin Exp Rheumatol; 2003; 21(2):171-7. PubMed ID: 12747270 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of diacerein on the symptoms and radiographic progression of osteoarthritis]. Provvedini D; Cohen P Presse Med; 2002 Dec; 31(39 Pt 2):4S13-5. PubMed ID: 12518072 [TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of diacerein. Nicolas P; Tod M; Padoin C; Petitjean O Clin Pharmacokinet; 1998 Nov; 35(5):347-59. PubMed ID: 9839088 [TBL] [Abstract][Full Text] [Related]
12. Diacerein-thymol prodrug: in vivo release and pharmacological screening in experimental models of osteoarthritis in Wistar rats. Patil D; Dhaneshwar S; Kadam P Inflamm Allergy Drug Targets; 2015; 13(6):393-405. PubMed ID: 25675406 [TBL] [Abstract][Full Text] [Related]
13. Rhein, an active metabolite of diacerein, suppresses the interleukin-1alpha-induced proteoglycan degradation in cultured rabbit articular chondrocytes. Tamura T; Ohmori K Jpn J Pharmacol; 2001 Jan; 85(1):101-4. PubMed ID: 11243562 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption. Tamura T; Shirai T; Kosaka N; Ohmori K; Takafumi N Eur J Pharmacol; 2002 Jul; 448(1):81-7. PubMed ID: 12126975 [TBL] [Abstract][Full Text] [Related]
15. Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1. Felisaz N; Boumediene K; Ghayor C; Herrouin JF; Bogdanowicz P; Galerra P; Pujol JP Osteoarthritis Cartilage; 1999 May; 7(3):255-64. PubMed ID: 10329300 [TBL] [Abstract][Full Text] [Related]
16. Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling. Boileau C; Tat SK; Pelletier JP; Cheng S; Martel-Pelletier J Arthritis Res Ther; 2008; 10(3):R71. PubMed ID: 18578867 [TBL] [Abstract][Full Text] [Related]
17. Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis. Tamura T; Ohmori K Eur J Pharmacol; 2001 May; 419(2-3):269-74. PubMed ID: 11426851 [TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Rintelen B; Neumann K; Leeb BF Arch Intern Med; 2006 Sep; 166(17):1899-906. PubMed ID: 17000948 [TBL] [Abstract][Full Text] [Related]
19. Diacerein as a disease-modulating agent in osteoarthritis. Falgarone G; Dougados M Curr Rheumatol Rep; 2001 Dec; 3(6):479-83. PubMed ID: 11709109 [TBL] [Abstract][Full Text] [Related]
20. Targeting of diacerein loaded lipid nanoparticles to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. Jain A; Mishra SK; Vuddanda PR; Singh SK; Singh R; Singh S Nanomedicine; 2014 Jul; 10(5):1031-40. PubMed ID: 24512762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]